CHAPTER VIII
PRELIMINARY WORKING BIBLIOGRAPHY
[1] Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and
epidemiology of 2019 novel coronavirus: implications for virus origins and
receptor binding. Lancet. 2020;395(10224):565–74.
[2] Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus
from patients with pneumonia in China, 2019. N Engl J Med.
2020;382(8):727–33.
[3] Yin Y, Wunderink RG. MERS, SARS and other coronaviruses as causes of
pneumonia. Respirology. 2018;23(2):130–7.
[4] Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia
outbreak associated with a new coronavirus of probable bat origin. Nature.
2020. https://doi.org/10.1038/ s41586-020-2012-7.
[5] Giovanetti M, Benvenuto D, Angeletti S, Ciccozzi M. The first two cases of
2019-nCoV in Italy: where they come from? J Med Virol. 2020:1–4.
https://doi.org/10.1002/jmv.25699
[6] Paraskevis D, Kostaki EG, Magiorkinis G, Panayiotakopoulos G, Sourvinos
G, Tsiodras S. Full-genome evolutionary analysis of the novel corona virus
(2019-nCoV) rejects the hypothesis of emergence as a result of a recent
recombination event. Infect Genet Evol. 2020;79:104212.
[7] Hampton T. Bats may be SARS reservoir. JAMA. 2005;294(18):2291.
[8] Banerjee A, Kulcsar K, Misra V, Frieman M, Mossman K. Bats and
coronaviruses. Viruses. 2019;11(1):E41. https://doi.org/10.3390/v11010041.
36
[9] Li W, Shi Z, Yu M, Ren W, Smith C, Epstein JH, et al. Bats are natural
reservoirs of SARS-like coronaviruses. Science. 2005;310(5748):676–9.
[10] Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, et al. A new
coronavirus associated with human respiratory disease in China. Nature.
2020. https://doi.org/10.1038/s41586-020-2008-3
[11] Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical
characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020.
[12] Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics
of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia
in Wuhan, China. JAMA. 2020.
[13] Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of
patients infected with 2019 novel coronavirus in Wuhan, China. Lancet.
2020;395(10223):497–506.
[14] Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological
and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia
in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–13.
[15] Lee N, Hui D, Wu A, Chan P, Cameron P, Joynt GM, et al. A major
outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med.
2003;348(20):1986–94.
[16] Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, Al-Rabiah FA, Al-Hajjar S, Al-
Barrak A, et al. Epidemiological, demographic, and clinical characteristics of
47 cases of Middle East respiratory syndrome coronavirus disease from
Saudi Arabia: a descriptive study. Lancet Infect Dis. 2013;13(9):752–61.
37
[17] Wang H, Xiao X, Lu J, Chen Z, Li K, Liu H, et al. Factors associated with
clinical outcome in 25 patients with avian influenza a (H7N9) infection in
Guangzhou, China. BMC Infect Dis. 2016;16(1):534.
[18] Kui L, Fang YY, Deng Y, Liu W, Wang MF, Ma JP, et al. Clinical
characteristics of novel coronavirus cases in tertiary hospitals in Hubei
Province. Chin Med J. 2020. https://doi.org/10.1097/CM9.0000000000000744
[19] Chung M, Bernheim A, Mei X, Zhang N, Huang M, Zeng X, et al. CT
imaging features of 2019 novel coronavirus (2019-nCoV). Radiology.
2020;200230. https://doi.org/10.1148/radiol.2020200230.
[20] Liu J, Liao X, Qian S et al. Community transmission of severe acute
respiratory syndrome coronavirus 2, Shenzhen, China, 2020. Emerg Infect
Dis 2020 doi.org/10.3201/eid2606.200239
[21] Chan J, Yuan S, Kok K et al. A familial cluster of pneumonia associated
with the 2019 novel coronavirus indicating person-to-person transmission: a
study of a family cluster. Lancet 2020 doi: 10.1016/S0140-6736(20)30154-9
[22] Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China,
of novel coronavirus-infected pneumonia. N Engl J Med 2020;
doi:10.1056/NEJMoa2001316.
[23] Burke RM, Midgley CM, Dratch A, Fenstersheib M, Haupt T, Holshue M,et
al. Active monitoring of persons exposed to patients with confirmed COVID-
19 — United States, January–February 2020. MMWR Morb Mortal Wkly Rep.
2020 doi : 10.15585/mmwr.mm6909e1external icon
38
[24] World Health Organization. Report of the WHO-China Joint Mission on
Coronavirus Disease 2019 (COVID-19) 16-24 February 2020 [Internet].
Geneva: World Health Organization; 2020 Available from:
https://www.who.int/docs/default- source/coronaviruse/who-china-joint-
mission-on-covid-19-final-report.pdf
[25] Ong SW, Tan YK, Chia PY, Lee TH, Ng OT, Wong MS, et al. Air, surface
environmental, and personal protective equipment contamination by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic
patient. JAMA. 2020 Mar 4 [Epub ahead of print].
[26] Wang W, Xu Y, Ruqin G, et al. Detection of SARS-CoV-2 in Different
Types of Clinical Specimens. JAMA2020 doi:10.1001/jama.2020.3786.
[27] Lauer SA, Grantz KH, Bi Q et al. The Incubation Period of Coronavirus
Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases:
Estimation and Application. Ann Intern Med2020 doi: 10.7326/M20-0504.
[28] Liu Y, Yan LM, Wan L et al. Viral dynamics in mild and severe cases of
CVOID-19. Lancet Infect Dis doi.org/10.1016/S1473-3099(20)30232-2
[29] Wolfel R, Corman V, Guggemos W et al Virological assessment of
hospitalized cases of coronavirus disease 2019. doi:
10.1101/2020.03.05.20030502.
[30] Yu P, Zhu J, Zhang Z, Han Y. A familial cluster of infection associated with
the 2019 novel coronavirus indicating possible person-to-person transmission
during the incubation period. J Infect 2020 doi: 10.1093/jiaa077
39
[31] Huang R, Xia J, Chen Y, Shan C, Wu C. A family cluster of SARS-CoV-2
infection involving 11 patients in Nanjing, China Lancet Infect Dis 2020 doi:
10.1016/ S1473-3099(20)30147-X
[32] Pan X, Chen D, Xia Y et al. Asymptomatic cases in a family cluster with
SARS-CoV-2 infection. Lancet Infect Dis 2020 doi: 10.1016/ S1473-
3099(20)30114-6
[33] Tong Z-D, Tang A, Li K-F, Li P, Wang H-L, Yi J-P, et al. Potential
presymptomatic transmission of SARS-CoV-2, Zhejiang Province, China,
2020. Emerg Infect Dis. 2020 doi: 10.3201/eid2605.200198
[34] Wei WE, Li Z, Chiew CJ, Yong SE, et al. Presymptomatic Transmission of
SARS-CoV-2 —Singapore, January 23–March 16, 2020. MMWR, 1 April
2020/69.
[35] Kimball A, Hatfield KM, Arons M, James A, et al. Asymptomatic and
Presymptomatic SARS-CoV-2 Infections in Residents of a Long-Term Care
Skilled Nursing Facility —King County, Washington, March 2020. MMWR, 3
April 2020, 69(13);377–381.
[36] World Meters, Covid-19 Coronavirus Pandemic, available at
https://www.worldometers.info/coronavirus/?utm_campaign=homeAdvegas1?
%20
[37] Barbera J, Macintyre A, Gostin L, Inglesby T, O'Toole T, DeAtley C, Tonat
K, Layton M: Large-Scale Quarantine Following Biological Terrorism in the
United States: Scientific Examination, Logistic and Legal Limits, and Possible
Consequences. JAMA. 2001, 286: 2711-2717. 10.1001/jama.286.21.2711.
40
[38] Reich DS: Modernizing local responses to public health emergencies:
Bioterrorism, epidemics, and the Model State Emergency Health Powers Act.
Journal of Contemporary Health Law and Policy. 2003, 19: 379-414.
[39] Lemon SM, Hamburg MA, Sparling PF, Choffnes ER, Mack A: Ethical and
legal considerations in mitigating pandemic disease: workshop summary.
2007, Washington, DC: Institute of Medicine. National Academy of Sciences
[40] Schabas R: Severe acute respiratory syndrome: Did quarantine help?.
Can J Infect Dis Med Microbiol. 2004, 15 (4): 204-
[41] Knobler S, Mahmoud A, Lemon S, Pray L, Eds: The Global Application of
Knowledge, Tools, and Technology: Opportunities and Obstacles. The Impact
of Globalization on Infectious Disease Emergence and Control: Exploring the
Consequences and Opportunities Workshop Report. 2006, Washington, DC:
Institute of Medicine, National Academy of Sciences, 80-124.
[42] Bauch CT, Lloyd-Smith JO, Coffee MP, Galvani AP: Dynamically Modeling
SARS and Other Newly Emerging Respiratory Illnesses: Past, Present and
Future. Epidemiology. 2005, 16: 791-801.
10.1097/01.ede.0000181633.80269.4c.
[43] Bensimon CM, Upshur RE: Evidence and effectiveness in decision making
for quarantine. American Journal of Public Health. 2007, 97: S44-S48.
10.2105/AJPH.2005.077305.
[44] R. Lu, X. Zhao, J. Li, P. Niu, B. Yang, H. Wu, et al. Genomic
characterization and epidemiology of 2019 novel coronavirus: implications for
virus origins and receptor binding Lancet (2020).
41
[45] P. Zhou, X.L. Yang, X.G. Wang, B. Hu, L. Zhang, W. Zhang, et al.A
pneumonia outbreak associated with a new coronavirus of probable bat origin
Nature (2020).
[46] Q. Li, X. Guan, P. Wu, X. Wang, L. Zhou, Y. Tong, et al. Early
transmission dynamics in Wuhan, China, of novel coronavirus-infected
pneumonia N Engl J Med, 382 (13) (2020), pp. 1199-1207
[47] W. Yu, G. Tang, L. Zhang, R. Corlett Decoding the evolution and
transmissions of the novel pneumonia coronavirus (SARS-CoV-2) using
whole genomic data ChinaXiv (2020)
[48] J.F. Chan, S. Yuan, K.H. Kok, K.K. To, H. Chu, J. Yang, et al.A familial
cluster of pneumonia associated with the 2019 novel coronavirus indicating
person-to-person transmission: a study of a family cluster Lancet (2020)
[49] A. Kramer, I. Schwebke, G. Kampf How long do nosocomial pathogens
persist on inanimate surfaces? A systematic review BMC Infect Dis, 6 (2006),
p. 130
[50] G. Kampf, D. Todt, S. Pfaender, E. Steinmann Persistence of
coronaviruses on inanimate surfaces and its inactivation with biocidal agents
J Hosp Infect (2020)
[51] C. Rothe, M. Schunk, P. Sothmann, G. Bretzel, G. Froeschl, C. Wallrauch,
et al. Transmission of 2019-nCoV infection from an asymptomatic contact in
Germany N Engl J Med (2020)
[52] K. Kupferschmidt Study claiming new coronavirus can be transmitted by
people without symptoms was flawed Science news (2020)
42
[53] C. Huang, Y. Wang, X. Li, L. Ren, J. Zhao, Y. Hu, et al. Clinical features of
patients infected with 2019 novel coronavirus in Wuhan, China Lancet, 395
(10223) (2020), pp. 497-506
[54] D.K.W. Chu, Y. Pan, S.M.S. Cheng, K.P.Y. Hui, P. Krishnan, Y. Liu, et al.
Molecular diagnosis of a novel coronavirus (2019-nCoV) causing an outbreak
of pneumonia Clin Chem (2020)
[55] Global surveillance for human infection with novel coronavirus (2019-
nCoV) World Health Organization (2020)
[56] C. Bauch, T. OrabyAssessing the pandemic potential of MERS-CoV
Lancet, 382 (9893) (2013), pp. 662-664
[57] S. Riley, C. Fraser, C.A. Donnelly, A.C. Ghani, L.J. Abu-Raddad, A.J.
Hedley, et al. Transmission dynamics of the etiological agent of SARS in
Hong Kong: impact of public health interventions Science, 300 (5627) (2003),
pp. 1961-1966
[58] Y. Yang, J.D. Sugimoto, M.E. Halloran, N.E. Basta, D.L. Chao, L. Matrajt,
et al. The transmissibility and control of pandemic influenza A (H1N1) virus
Science, 326 (5953) (2009), pp. 729-733
[59] Y. Liu, A. Gayle, A. Wilder-Smith JR. The reproductive number of COVID-
19 is higher compared to SARS coronavirus J Travel Med (2020),
10.1093/jtm/taaa021
[60] A. Kucharski, C. Althaus The role of super spreading in Middle East
respiratory syndrome coronavirus (MERS-CoV) transmission Euro Surveill, 20
(25) (2015) pii:21167
43
[61] H.E.A. Chen Clinical characteristics and intrauterine vertical transmission
potential of COVID-19 infection in nine pregnant women: a retrospective
review of medical records Lancet (2020), 10.1016/S0140-6736(20)30360-3
[62] D. Wang, B. Hu, C. Hu, F. Zhu, X. Liu, J. Zhang, et al. Clinical
characteristics of 138 hospitalized patients with 2019 novel coronavirus-
infected pneumonia in Wuhan, China JAMA (2020)
[63] Y. Bai, L. Yao, T. Wei, F. Tian, D.Y. Jin, L. Chen, et al. Presumed
asymptomatic carrier transmission of COVID-19 JAMA (2020)
[64] Chang, M. Lin, L. Wei, L. Xie, G. Zhu, C.S. Dela Cruz, et al. Epidemiologic
and clinical characteristics of novel coronavirus infections involving 13
patients outside Wuhan, China JAMA (2020)
[65] N. Chen, M. Zhou, X. Dong, J. Qu, F. Gong, Y. Han, et al. Epidemiological
and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia
in Wuhan, China: a descriptive study Lancet (2020)
[66] W. Liu, Q. Zhang, J. Chen, R. Xiang, H. Song, S. Shu, et al. Detection of
Covid-19 in children in early January 2020 in Wuhan, China N Engl J Med,
382 (14) (2020), pp. 1370-1371
[67] J.F.-W. Chan, S. Yuan, K.-H. Kok, K.K.-W. To, H. Chu, J. Yang, et al.A
familial cluster of pneumonia associated with the 2019 novel coronavirus
indicating person-to-person transmission: a study of a family cluster Lancet
(2020)
[68] C.D.C. China, Epidemic update and risk assessment of 2019 novel
coronavirus Chinese Center for Diseases Control and Prevention (2020)
44
http://www.chinacdc.cn/yyrdgz/202001/P020200128523354919292.pdf
[accessed 18 May 2020]
[69] A. Patel, D.B. Jernigan, Initial public health response and interim clinical
guidance for the 2019 novel coronavirus outbreak—United States, December
31, 2019–February 4, 2020 ,MMWR Morb Mortal Wkly Rep, 69 (2020), p. 140
[70] J.W. Tang, P.A. Tambyah, D.S.C. Hui, Emergence of a novel coronavirus
causing respiratory illness from Wuhan, China J Infect (2020)
[71] P. Habibzadeh, E.K. StonemanThe novel coronavirus: a bird's eye view Int
J Occup Environ Med, 11 (2) (2020), pp. 65-71
[72] Organization WH Global surveillance for human infection with novel
coronavirus (2019-nCoV) (2020)
[73] C. Gidengil, A. Parker, B. Zikmund-Fisher, Trends in risk perceptions and
vaccination intentions: a longitudinal study of the first year of the H1N1
pandemic Am J Public Health, 102 (2012), pp. 672-679
[74] Organization WH, Clinical management of severe acute respiratory
infection when novel coronavirus (2019-nCoV) infection is suspected (2020)
[75] C. Russell, J. Millar, J. Baillie, Clinical evidence does not support
corticosteroid treatment for 2019-nCoV lung injury Lancet, 395 (10223)
(2020), pp. 473-475
[76] C.I. Paules, H.D. Marston, A.S. Fauci, Coronavirus infections – more than
just the common cold JAMA (2020)
45
[77] M.L. Holshue, C. DeBolt, S. Lindquist, K.H. Lofy, J. Wiesman, H. Bruce, et
al. First case of 2019 novel coronavirus in the United States N Engl J Med
(2020)
[78] Z. Wang, X. Chen, Y. Lu, F. Chen, W. Zhang, Clinical characteristics and
therapeutic procedure for four cases with 2019 novel coronavirus pneumonia
receiving combined Chinese and Western medicine treatment Biosci Trends
(2020)
[79] M. Wang, R. Cao, L. Zhang, X. Yang, J. Liu, M. Xu, et al.Remdesivir and
chloroquine effectively inhibit the recently emerged novel coronavirus (2019-
nCoV) in vitro Cell Res (2020)
[80] E. de Wit, F. Feldmann, J. Cronin, R. Jordan, A. Okumura, T. Thomas, et
al. Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus
macaque model of MERS-CoV infection Proc Natl Acad Sci USA, 3 (2020), p.
20192208
[81] X. Liu, X.-J. Wang, Potential inhibitors for 2019-nCoV coronavirus M
protease from clinically approved medicines bioRxiv (2020)
2020.2001.2029.924100
[82] H. Lu, Drug treatment options for the 2019-new coronavirus (2019-nCoV)
Biosci Trends (2020)
[83] World Health Organization (2012), Rapid Risk Assessment of Acute Public
Health Events, available at https://apps.who.int/iris/bitstream/handle
/10665/70810/WHO_HSE_GAR_ARO_2012.1_eng.pdf?sequence=1
46
